{
    "nct_id": "NCT05764161",
    "official_title": "A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis",
    "inclusion_criteria": "* Clinical diagnosis of PN ≥ 3 months before screening.\n* ≥ 6 pruriginous lesions on ≥ 2 different body areas (such as right and left leg) at screening and baseline having a treatment area <20% BSA.\n* IGA-CPG-S score of ≥ 2 at screening and baseline.\n* Baseline PN-related WI-NRS score ≥ 7.\n* Willingness to avoid pregnancy or fathering children.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
    "exclusion_criteria": "* Chronic pruritus due to a condition other than PN\n* Total estimated BSA treatment area (excluding the scalp) > 20%.\n* Neuropathic and psychogenic pruritus\n* Active atopic dermatitis lesions within 3 months of screening and baseline.\n* Uncontrolled thyroid function\n* Concurrent skin or other serious or unstable medical conditions which may interfere with the evaluation of PN such as immunocompromised status, acute/chronic infections, active malignancy, history of TB, history of DVT/VTE, etc Protocol defined abnormal laboratory results.\n* Use of any protocol-defined prohibited medication unless a washout is completed or use of medication known to cause itching.\n* Psoralen and ultraviolet A or ultraviolet B therapy within 4 weeks before baseline or Ultraviolet light therapy or prolonged exposure to natural or artificial sources of ultraviolet radiation (within 2 weeks before baseline\n* Pregnant or lactating, or considering pregnancy.\n* History of alcoholism or drug addiction within 1 year\n* Known allergy or reaction to any of the components of the study drug.\n* Committed to a mental health institution by virtue of an order issued either by the judicial or the administrative authorities.\n* Employees of the sponsor or investigator or otherwise dependents of them.\n* The following participants are excluded in France:\n\n  1. Vulnerable populations according to article L.1121-6 of the French Public Health Code.\n  2. Adults under legal protection or who are unable to express their consent per article L.1121-8 of the French Public Health Code.\n  3. Individuals not affiliated with the social security system.",
    "miscellaneous_criteria": ""
}